GSK Stock - Weekly outlook with earnings on the horizon
22.06.2026 - 09:04:05 | ad-hoc-news.de
Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 09:02 CET. Details in the imprint.
GSK (GB0009252882) starts the new week with the market looking ahead to its next quarterly figures and pipeline updates. The next earnings date is currently indicated for 07/29/2026, according to market data providers.
All news and key figures on GSK stock
Follow the latest disclosures, product headlines and price data for GSK stock in one place.
What the calendar shows
After closing last week, GSK stock trades around $50.74 in New York, roughly 1.3% lower than 30 days ago, based on recent market data. The indicated next earnings release on 07/29/2026 gives investors a concrete date to monitor.
Consensus expects the coming updates to cover performance in key franchises such as vaccines and HIV, as well as any refinements to full-year guidance. The company usually posts detailed segment data and pipeline commentary in its quarterly materials.
Weekly outlook for investors
This week, the focus is likely to stay on sector news, macro data and any incremental pipeline updates from GSK rather than scheduled company events. The group does not list a major capital markets day or strategy presentation on its investor calendar in the next few days.
Against this backdrop, investors may pay attention to peer news from other large pharmaceutical names and regulatory decisions that could read across to GSK. Broader market moves in indices like the Standard & Poor's 500 index and healthcare benchmarks can also influence trading in the shares.
How the company makes money
GSK generates revenue primarily from prescription medicines, vaccines and specialty therapies. A central product is the respiratory syncytial virus (RSV) vaccine Arexvy, which has become a key growth driver since its first approvals in major markets.
Where the stock trades today
The shares of GSK (GB0009252882) trade on the New York Stock Exchange at about $50.74 as of 06/22/2026, 09:02 CET, alongside their primary London listing.
Key facts on GSK stock
- Company: GSK plc
- ISIN: GB0009252882
- WKN: 940561
- Ticker: GSK
- Venue: NYSE
- Price (as of 06/22/2026, 09:02 CET): 50.74 USD
- Market cap: 103,000,000,000 USD (as of 06/22/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: FTSE 100
- Next earnings date: 07/29/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
